Time to Benefit Estimated for Intensive BP Control to Prevent Stroke
WEDNESDAY, Feb. 9, 2022 (HealthDay News) -- About 1.7 years of more intensive hypertensive treatment would be needed to prevent one stroke per 200 older adults, according to research published online Feb. 9 in the Journal of the American Geriatrics Society.
Vanessa S. Ho, from California Northstate University in Elk Grove, and colleagues conducted a meta-analysis to estimate the time to benefit (TTB) for stroke prevention after initiation of more intensive hypertension treatment in adults aged 65 years or older. Data were abstracted from randomized controlled trials comparing standard to more intensive treatment groups among older adults. Data were included from nine trials, with 38,779 individuals.
The researchers found that for 200 persons receiving more intensive hypertensive treatment, 1.7 years were required to prevent one stroke. Across studies, there was heterogeneity; longer TTB was seen for studies focusing on tighter systolic blood pressure (SBP) control (SBP <150 mm Hg). In the SPRINT study (baseline SBP, 140 mm Hg; achieved SBP, 121 mm Hg), the TTB was 59 years to avoid one stroke for 200 treated patients.
"These results suggest that almost all older adults with hypertension would benefit from treatment," the authors write. "For older adults with relatively well-controlled hypertension (i.e., SBP <150 mm Hg), the TTB to prevent one stroke for 200 persons treated is likely substantially longer than 1.7 years."
Related Posts
One Drug Clear Winner in Treating Acne: Review
MONDAY, July 31, 2023 (HealthDay News) – Millions of people live with acne, and...
Barriers to Advance Care Planning ID’d for Sexual/Gender Minorities
THURSDAY, Aug. 4, 2022 (HealthDay News) -- Discrimination in the health care...
Feds Warn of 14 Infant Deaths in Rockers From Fisher-Price, Kids2
WEDNESDAY, June 15, 2022 (HealthDay News) -- At least 13 infant deaths have been...
Uncontrolled Heart Risk Factors Common in Head, Neck Squamous Cell Cancer
THURSDAY, June 29, 2023 (HealthDay News) -- The burden of suboptimally...